Key statistics dashboard for Evogene Ltd. (EVGN). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Evogene Ltd., along with its subsidiaries, operates as a computational biology firm. Its core activity involves the discovery and advancement of products across diverse life-science sectors, such as human health and agriculture, primarily leveraging its proprietary Computational Predictive Biology (CPB) platform.
Stock Data
| Price | $0.50 |
| Market Cap | $4M |
| Enterprise Value | -$2.9M |
| Beta | 0.95 |
| Exchange | NASDAQ |
| Country | IL |
Valuation Multiples
| P/E Ratio | -0.57 |
| Price / Book | -1.93 |
| P/S | 3.44 |
| EV/EBITDA | 0.24 |
| EV/Sales | -2.19 |
| EV/FCF | 0.24 |
| P/FCF | -0.38 |
| Earnings Yield | -148.06% |
| FCF Yield | -273.99% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | -14.16% |
| EBIT Margin | -985.45% |
| EBITDA Margin | -916.93% |
| Operating Margin | -1020.35% |
| Net Margin | -696.26% |
| Return on Equity | 761.97% |
| Return on Assets | -67.68% |
| Return on Invested Capital | -113.67% |
| Return on Capital Employed | -128.22% |
Financial Health
| Current Ratio | 3.57 |
| Quick Ratio | 3.54 |
| Cash Ratio | 3.05 |
| Debt / Equity | -0.63 |
| Debt / Assets | 15.51% |
| Net Debt / EBITDA | 0.60 |
| Interest Coverage | -2.73 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -20.48 |
Per-Share Data
| Revenue per share | 0.11 |
| Book Value per share | 0.47 |
| Cash per share | 0.76 |
| FCF per share | -0.97 |
| Tangible Book Value per share | 0.47 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 4 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 4 |
| Avg rating (1-5) | 1.00 |
Related companies: AEON · BOLT · CING · CLRB · COCP · DWTX · GLTO
Explore sector: Healthcare · Biotechnology
More sections of EVGN: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks